Priming with GM-CSF for acute myelogenous leukemia (AML): GOELAM data

Ann Hematol. 2004:83 Suppl 1:S55-7. doi: 10.1007/s00277-004-0849-8.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antimetabolites, Antineoplastic / therapeutic use
  • Combined Modality Therapy
  • Cytarabine / therapeutic use
  • Drug Administration Schedule
  • Granulocyte-Macrophage Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Middle Aged
  • Recombinant Proteins

Substances

  • Antimetabolites, Antineoplastic
  • Recombinant Proteins
  • Cytarabine
  • Granulocyte-Macrophage Colony-Stimulating Factor